This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.
Rite Aid Seems the Forbidden Fruit, Stock Down 20% in July
by Zacks Equity Research
Ever since Rite Aid Corp.'s (RAD) merger deal with Walgreens Boots Alliance Inc. (WBA) fell through on Jun 29, the stock has turned in to a forbidden fruit for investors.
Fred's Posts Dismal Comparable June Store Sales, Stock Down
by Zacks Equity Research
Fred's, (FRED), which has been struggling to recover from the blow of a failed merger between Rite Aid Corporation (RAD) and Walgreens Boots Alliance (WBA), recently announced soft June comparable store sales.
Fred's Stock Falls, Walgreens & Rite Aid Merger Deal Revised
by Zacks Equity Research
Fred's, Inc. (FRED) or Fred's Pharmacy lost over 20% yesterday after Walgreens Boots Alliance, Inc. (WBA) decided not to proceed with its planned takeover of the rival drugstore Rite Aid Corporation (RAD) due to various antitrust issues, as per Bloomberg. The cancelled merger significantly hurt Rite Aid???s stock too, which fell 26.46% yesterday.
Have You Noticed Potential in Herbalife? Stock Adds 48% YTD
by Zacks Equity Research
Shares of Herbalife (HLF) have exhibited a bullish run on the index.
What Will Rite Aid-Walgreens Merger Mean to Fred's (FRED)?
by Zacks Equity Research
Shares of Fred's (FRED) rallied nearly 23% on Jun 26 on rumors about the FTC approval of the acquisition of Rite Aid by Walgreens.
CVS Health (CVS) Down 3.6% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Could Amazon Be the Next Big Pharmacy Giant?
by Madeleine Johnson
Amazon is reportedly looking to expand into new territory. According to CNBC, the e-commerce giant is trying to figure out how it can break into the multi-billion-dollar pharmacy industry.
The Zacks Analyst Blog Highlights: MasterCard, CVS Health, Colgate-Palmolive, Charter Communications and Norfolk Southern
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MasterCard, CVS Health, Colgate-Palmolive, Charter Communications and Norfolk Southern
Top Research Reports for Today: MA, CVS, CL & More
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including MasterCard (MA), CVS Health (CVS) and Colgate-Palmolive (CL).
CVS Health Beats on Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Currently, CVS Health has a Zacks Rank #3 (Hold) but that could change following its first quarter 2017 earnings report which has just released.
Rite Aid (RAD) Stock Up on Better-than-Expected Q4 Results
by Zacks Equity Research
Rite Aid (RAD) posted fourth-quarter fiscal 2017 results.
CVS Health Launches Reduced Rx for Affordable Medication
by Zacks Equity Research
CVS Health Corporation (CVS), a leading name in pharmacy benefit and retail pharmacy, recently announced the launch of a prescription savings program-Reduced Rx.
CVS Health (CVS) Up 4% Since Earnings Report: Can It Continue?
by Zacks Equity Research
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CVS Health Adopts Epic EHR for Specialty Care Programs
by Zacks Equity Research
CVS Health Corporation (CVS) recently announced that it has chosen Epic as the electronic health record (EHR) system for CVS Specialty's care management programs.
CVS Health (CVS) Beats on Q4 Earnings, Retains '17 View
by Zacks Equity Research
CVS Health Corporation (CVS) reported fourth-quarter 2016 adjusted earnings per share (EPS) of $1.71, up 11.8% year over year.
CVS Health Tops Q4 Earnings, Misses on Revenues
by Zacks Equity Research
CVS Health posted mixed fourth quarter results with earnings beating the Zacks Consensus Estimate while sales missed the mark.
Paycom Software (PAYC) Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Paycom Software, Inc. (PAYC) is set to report fourth-quarter 2016 results on Feb 8.
Broadridge Financial (BR) Q2 Earnings: What's in Store?
by Zacks Equity Research
Broadridge Financial Solutions Inc. (BR) is set to report fiscal second-quarter 2017 results on Feb 8.
CDW Corp. (CDW) Q4 Earnings: What's in the Cards this Time?
by Zacks Equity Research
CDW Corp. (CDW) is set to report fourth-quarter 2016 results on Feb 7.
Marsh & McLennan (MMC): Will it Disappoint in Q4 Earnings? (Revised)
by Zacks Equity Research
Marsh & McLennan Companies, Inc. (MMC) is scheduled to report fourth-quarter and full-year 2016 results on Feb 2.
Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4? (Revised)
by Zacks Equity Research
We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.
Marsh & McLennan (MMC): Will it Disappoint in Q4 Earnings?
by Zacks Equity Research
Marsh & McLennan Companies, Inc. (MMC) is scheduled to report fourth-quarter and full-year 2016 results on Feb 2.
Can Cigna (CI) Sustain its Earnings Surprise Streak in Q4?
by Zacks Equity Research
We expect Cigna Corp. (CI) to beat earnings expectations when it reports fourth-quarter and full-year 2016 results, on Feb 2.
Rite Aid Down on Walgreens Deal Offer Price Cut & Delay
by Zacks Equity Research
Rite Aid Corp. (RAD) and Walgreens Boots Alliance Inc. (WBA) jointly agreed upon a Jul 31, 2017 deadline for the deal and slashed the offer price to accommodate more store divestitures that would help gain regulatory approval.
Paylocity Holding (PCTY) Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Paylocity Holding Corporation (PCTY) is set to report second-quarter fiscal 2017 results on Feb 2.